Cardiovascular Drugs Practice Questions

Q: Which of the following adverse effects of ACE inhibitors is primarily due to the inhibition of aldosterone secretion?

Hyperkalemia. ***Hyperkalemia*** - **Angiotensin II** stimulates aldosterone secretion, and **ACE inhibitors** block angiotensin II formation, leading to reduced aldosterone. - **Aldosterone** promotes sodium reabsorption and potassium excretion in the renal tubules, so its reduction causes **potassium retention** and **hyperkalemia**. - This is the primary adverse effect mediated through the **aldosterone pathway**. *Respiratory tract irritation* - This is primarily due to the accumulation of **bradykinin** and **substance P** in the airways, not due to the inhibition of aldosterone. - ACE is responsible for bradykinin breakdown, so its inhibition leads to **bradykinin accumulation** causing cough. *Facial swelling* - This is a symptom of **angioedema**, which is related to the accumulation of **bradykinin** due to ACE inhibition, not due to aldosterone inhibition. - Bradykinin causes **vasodilation** and increased vascular permeability. *Hypotension* - While hypotension can occur with ACE inhibitors, it is primarily due to reduced formation of the potent vasoconstrictor **angiotensin II**, causing **decreased systemic vascular resistance**. - This is NOT primarily mediated through the aldosterone pathway, but through direct vascular effects.

Q: Beta-blockers should be used with caution in patients with?

Conduction defect. ***Conduction defect*** - Beta-blockers **slow heart rate** and **decrease AV nodal conduction**, which can worsen pre-existing conduction defects like **AV block** or **sick sinus syndrome**. - Their use can lead to **symptomatic bradycardia** or complete heart block in susceptible individuals. - This represents a **strong relative contraindication** requiring significant caution. *Hypertension* - Beta-blockers are a **first-line treatment for hypertension**, effectively lowering blood pressure by reducing cardiac output and renin release. - They are generally **well-tolerated** and beneficial in most hypertensive patients. *Glaucoma* - Topical beta-blockers, such as **timolol**, are a common treatment for open-angle glaucoma as they **reduce aqueous humor production**, thereby lowering intraocular pressure. - Systemic use of beta-blockers does not typically worsen glaucoma and may even offer some benefit. *CHF* - While certain beta-blockers (**carvedilol, metoprolol succinate, bisoprolol**) are now proven beneficial in **chronic heart failure with reduced ejection fraction (HFrEF)**, they do require careful use. - They must be **initiated at low doses and carefully titrated** to avoid acute decompensation, and are **contraindicated in acute decompensated heart failure**. - However, **conduction defects** represent a **stronger contraindication** where beta-blockers can cause life-threatening bradycardia or complete heart block, making it the best answer for conditions requiring the most caution.

Q: Which of the following is not a known side effect of amiodarone?

Hyperglycemia. ***Hyperglycemia*** - **Hyperglycemia** is generally **not recognized** as a direct or common side effect of amiodarone. - Amiodarone's primary action is on cardiac ion channels, and its metabolic effects typically involve thyroid function, not glucose regulation. *Hyperthyroidism* - Amiodarone contains **iodine**, which can induce **thyroid dysfunction**, including both hypo- and hyperthyroidism. - **Amiodarone-induced hyperthyroidism (AIH)** can occur due to increased thyroid hormone synthesis or destructive thyroiditis. *Peripheral neuropathy* - **Neurological side effects**, including **peripheral neuropathy**, are known to occur with chronic amiodarone use. - Symptoms often include **paresthesias**, weakness, and sensory loss in the extremities. *Skin discoloration* - Prolonged use of amiodarone can lead to **bluish-gray skin discoloration**, particularly in sun-exposed areas. - This is due to the **accumulation of amiodarone** and its metabolites in the skin.

Q: Which prostaglandin inhibitor is used in the treatment of patent ductus arteriosus (PDA)?

Indomethacin. ***Indomethacin*** - **Indomethacin** is a non-steroidal anti-inflammatory drug (**NSAID**) that inhibits **prostaglandin synthesis**, particularly **prostaglandin E2 (PGE2)**. - **PGE2** helps keep the **ductus arteriosus** open in utero; by inhibiting its production, indomethacin facilitates the closure of a **patent ductus arteriosus (PDA)** in neonates. *Misoprostol* - **Misoprostol** is a **prostaglandin E1 (PGE1) analog** and is used to induce labor, treat gastric ulcers, and for medical abortions. - It would work to **maintain** rather than close the **ductus arteriosus** if used in a neonate with a heart defect requiring patency. *Dinoprostone* - **Dinoprostone** is a **prostaglandin E2 analog** used for cervical ripening and labor induction. - It is not used for closing a **PDA**; its prostaglandin agonistic action would likely keep the **ductus arteriosus open**. *PGE-2* - **Prostaglandin E2 (PGE2)** is a naturally occurring prostaglandin that helps maintain the patency of the **ductus arteriosus** in the fetus. - Administering **PGE2** would keep the **ductus arteriosus open**, which is the opposite of the desired effect when treating a **PDA**.

Q: Which drug is used to keep the patent ductus arteriosus (PDA) open?

PGE1. ***PGE1*** - **Prostaglandin E1** (**PGE1**, alprostadil) is used to maintain the patency of the **ductus arteriosus** in neonates with certain congenital heart defects [1], [2]. - It acts as a **vasodilator** on the smooth muscle of the ductus, preventing its closure and allowing for adequate blood flow prior to surgical correction [1], [2]. *PGI2* - **Prostaglandin I2** (**PGI2**, prostacyclin) is a potent **vasodilator** and **platelet aggregation inhibitor** [1]. - While it has cardiovascular effects, it is primarily used for conditions like **pulmonary hypertension** and not for maintaining ductal patency [1]. *PGF2̑* - **Prostaglandin F2̑** (**PGF2̑**) is involved in processes such as **uterine contractions** and **bronchoconstriction** [1], [2]. - It does not play a role in maintaining the patency of the ductus arteriosus. *PGH2* - **Prostaglandin H2** (**PGH2**) is an immediate precursor in the synthesis of various other prostaglandins and thromboxanes. - It is not directly administered as a drug to maintain ductal patency but is an intermediate in their synthesis.

Q: What is the drug of choice for a classical angina attack?

GTN. ***GTN*** - **Glyceryl trinitrate (GTN)** is the drug of choice for immediate relief of a classical angina attack because it rapidly dilates coronary arteries and peripheral blood vessels, reducing **myocardial oxygen demand** and improving blood flow [2]. - Its **nitric oxide** mediated vasodilatory effects quickly alleviate chest pain by decreasing **preload** and afterload [2], [3]. *CCBs* - **Calcium channel blockers (CCBs)** are used for long-term prevention of angina by reducing myocardial oxygen demand, but they are not the first-line treatment for acute relief due to their slower onset of action [1]. - While they can dilate coronary arteries and reduce heart rate/contractility, their role is more in **prophylaxis** rather than acute symptom management [1]. *β-blocker* - **Beta-blockers** are primarily used for chronic management and prevention of angina by reducing heart rate, contractility, and blood pressure, thereby decreasing myocardial oxygen demand. - They are generally avoided for acute angina attacks as they do not provide rapid symptomatic relief and can potentially worsen symptoms in some acute ischemic conditions. *Prazocin* - **Prazosin** is an **alpha-1 adrenergic blocker** primarily used to treat hypertension and benign prostatic hyperplasia. - It causes vasodilation but is not indicated for the treatment of acute angina, as its mechanism of action and onset of effect are not suitable for rapid relief of myocardial ischemia.

Q: Which of the following is a renin inhibitor?

Remikiren. **Remikiren** - **Remikiren** is a direct **renin inhibitor** that acts by binding to the active site of renin, preventing its interaction with angiotensinogen. - This inhibition reduces the formation of **angiotensin I** and subsequently **angiotensin II**, leading to decreased blood pressure. *Losartan* - **Losartan** is an **Angiotensin II Receptor Blocker (ARB)**, meaning it blocks AT1 receptors, preventing angiotensin II from binding. - It does not inhibit renin activity directly but rather acts downstream in the **renin-angiotensin-aldosterone system (RAAS)**. *Benazepril* - **Benazepril** is an **Angiotensin-Converting Enzyme (ACE) inhibitor**, which blocks the enzyme responsible for converting **angiotensin I** to **angiotensin II**. - It does not directly inhibit renin production or activity. *Imidapril* - **Imidapril** is also an **Angiotensin-Converting Enzyme (ACE) inhibitor**, similar to benazepril. - Its mechanism of action involves inhibiting ACE, thereby reducing **angiotensin II** levels, rather than directly inhibiting renin.

Q: Drug of choice for familial hypercholesterolemia?

Lovastatin. ***Lovastatin*** - **Statins** (HMG-CoA reductase inhibitors) are the **first-line therapy** for familial hypercholesterolemia as they effectively lower **LDL cholesterol** levels by inhibiting cholesterol synthesis [1]. - While other agents can be used adjunctively, statins like lovastatin are the cornerstone for managing this genetic condition [2]. *Nicotinic acid* - **Nicotinic acid** (niacin) primarily lowers **triglycerides** and increases **HDL cholesterol**, but it is less potent than statins for reducing LDL-C, especially in familial hypercholesterolemia [1]. - Its use is often limited by significant **side effects** like flushing. *Cholestyramine* - **Cholestyramine** is a **bile acid sequestrant** that binds to bile acids in the intestine, preventing their reabsorption and mildly lowering LDL cholesterol. - It is less effective than statins and often causes **gastrointestinal side effects** such as constipation and bloating. *Gemfibrozil* - **Gemfibrozil** is a **fibrate**, primarily used to lower **triglyceride levels** and increase HDL cholesterol. - It has minimal impact on LDL cholesterol compared to statins and is not the primary treatment for familial hypercholesterolemia [2].

Q: All of the following are adverse effects of nicotinic acid except:

Pancreatitis. ***Pancreatitis*** - **Pancreatitis** is not a commonly reported adverse effect of nicotinic acid (niacin) therapy. - While other gastrointestinal side effects like nausea and vomiting can occur, pancreatic inflammation is not characteristic. *Vasodilation* - **Cutaneous flushing** and **vasodilation** are very common adverse effects of nicotinic acid, mediated by prostaglandin release. - This effect can cause a sensation of warmth, redness, and itching, especially at the start of therapy. *Liver dysfunction* - **Liver dysfunction**, including elevated liver enzymes and rare cases of **hepatotoxicity**, can occur with high doses of nicotinic acid. - Regular monitoring of liver function tests is recommended for patients on niacin therapy. *Hyperpigmentation* - **Hyperpigmentation**, particularly **acanthosis nigricans**, is a known cutaneous side effect of nicotinic acid. - This typically presents as dark, velvety patches on the skin, especially in skin fold areas.

Question 1

Which of the following adverse effects of ACE inhibitors is primarily due to the inhibition of aldosterone secretion?

Accepted Answer

Hyperkalemia

Answer

Respiratory tract irritation

Answer

Facial swelling

Answer

Hypotension

Question 2

Beta-blockers should be used with caution in patients with?

Accepted Answer

Conduction defect

Answer

Hypertension

Answer

CHF

Answer

Glaucoma

Question 3

Which of the following is not a known side effect of amiodarone?

Accepted Answer

Hyperglycemia

Answer

Peripheral neuropathy

Answer

Hyperthyroidism

Answer

Skin discoloration

Question 4

Which prostaglandin inhibitor is used in the treatment of patent ductus arteriosus (PDA)?

Accepted Answer

Indomethacin

Answer

PGE-2

Answer

Misoprostol

Answer

Dinoprostone

Question 5

Which drug is used to keep the patent ductus arteriosus (PDA) open?

Accepted Answer

PGE1

Answer

PGI2

Answer

PGH2

Answer

PGF2α

Question 6

Which of the following statements about hypolipidemic drugs is false?

Accepted Answer

Cholesterol reducing drugs are contraindicated in child less than 8 years

Answer

Gemfibrozil causes myopathy

Answer

Gemfibrozil can increase myopathy caused by statins

Answer

Lovastatin can cause hepatic dysfunction

Question 7

What is the drug of choice for a classical angina attack?

Accepted Answer

GTN

Answer

CCBs

Answer

β-blocker

Answer

Prazosin

Question 8

Which of the following is a renin inhibitor?

Accepted Answer

Remikiren

Answer

Losartan

Answer

Benazepril

Answer

Imidapril

Question 9

Drug of choice for familial hypercholesterolemia?

Accepted Answer

Lovastatin

Answer

Nicotinic acid

Answer

Cholestyramine

Answer

Gemfibrozil

Question 10

All of the following are adverse effects of nicotinic acid except:

Accepted Answer

Pancreatitis

Answer

Liver dysfunction

Answer

Vasodilation

Answer

Hyperpigmentation

Cardiovascular Drugs — MCQs

Cardiovascular Drugs — MCQs

On this page

Practice by Chapter

Want unlimited practice?